NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Beta is a flawed measure for penny stocks like this. It only takes ONE measure per month, over that 5 year period and we are closer to where we were 5 years ago now so it looks artificially and falsely less volatile.

I find these trading measures often not a lot better than astrological predictions.

But some measures that are suggested for penny stocks are:

Average True Range (ATR): Measures the average daily volatility of a stock.

Standard Deviation: Similar to ATR, but based on historical price movements over a specific period.

Sortino Ratio: Focuses on downside risk rather than total volatility.

Price-to-Sales Ratio (P/S): Can indicate overvaluation in penny stocks with limited profits

The point further is someone who bought a few hundred thousand here at one point might find their investment at a hundred thousand at one point or a little more and then over a million. And then back down again. Most investors seek steady market investments in commercial companies because they have steady income and that range is far more predictable.

I am not recommending anything, just pointing out the weakness in using the beta measure for a stock like this, it is useful sometimes and sometimes less meaningful.

And for investors, it is the potential and opportunity they are buying, so if they are satisfied, then the objective is to buy low and ultimately to sell high, so that volatility can work quite favorably for knowledgeable investors who are willing to embrace the risks of microcap biotechs and their long timelines.

It is the epitome of capitalism to invest in the small guy and see the business become a major economic, commercial and scientific force.

But small companies are less steady ships on a big ocean.